On 13 January 2025, GlyTherix Ltd and Eckert & Ziegler announced the expansion of their existing Lutetium-177-based collaboration with a global supply agreement for Actinium-225.
Eckert & Ziegler will provide high-quality Ac-225 to support GlyTherix’s clinical research and development activities on innovative alpha radiotherapeutics.